Ocugen, Inc. (OCGN) stock
OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.83−0.05 (-5.24%)
Close on Nov 13, 2026Market cap $280.72MP/E –Yield –
Ocugen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Ocugen's enterprise value was $227.32M on Nov 11, 2026, against $383.11M a year earlier. Over the last 5 years it ranged from $26.52M to $799.47M, with a median of $273.25M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $227.32M | -45.5% |
| 2025 | Dec 31, 2025 | $417.47M | +111.0% |
| 2024 | Dec 31, 2024 | $197.85M | +104.4% |
| 2023 | Dec 29, 2023 | $96.78M | -46.9% |
| 2022 | Dec 30, 2022 | $182.36M | -77.2% |
| 2021 | Dec 31, 2021 | $799.47M | +185.0% |
| 2020 | Dec 31, 2020 | $280.56M | – |
| 2019 | Dec 31, 2019 | -$9.04M | -131.8% |
| 2018 | Dec 31, 2018 | $28.45M | -93.7% |
| 2017 | Dec 29, 2017 | $454.52M | +100.2% |
| 2016 | Dec 30, 2016 | $227.01M | -46.8% |
| 2015 | Dec 31, 2015 | $426.85M | – |
See a number that looks wrong?